Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Allen

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Internal Medicine Journal|October 18, 2020
End-of-life intravenous chemotherapy administration patterns in the treatment of Queensland lung and pancreas cancer patients: a 10-year retrospective analysisMichael J Allen, Nathan Dunn, Tracey Guan, et al.
FEBS Open Bio|November 20, 2013
Mutations of an NAD(P)H-dependent flavoprotein monooxygenase that influence cofactor promiscuity and enantioselectivityChantel N Jensen, Sohail T Ali, Michael J Allen, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 12, 2010
Time-dependent measure of a nanoscale force-pulse driven by the axonemal dynein motors in individual live sperm cellsMichael J Allen, Robert E Rudd, Mike W McElfresh, et al.
Journal of Molecular Catalysis. B, Enzymatic|November 11, 2014
Exploring nicotinamide cofactor promiscuity in NAD(P)H-dependent flavin containing monooxygenases (FMOs) using natural variation within the phosphate binding loop. Structure and activity of FMOs from <i>Cellvibrio</i> sp. BR and <i>Pseudomonas stutzeri</i> NF13Chantel N Jensen, Sohail T Ali, Michael J Allen, et al.
British Journal of Clinical Pharmacology|November 18, 2003
Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safetyLynn Purkins, Nolan Wood, Katie Greenhalgh, et al.
Marine Drugs|February 10, 2021
Antiviral Potential of Algal Metabolites-A Comprehensive ReviewAntónio Pagarete, Ana Sofia Ramos, Pål Puntervoll, et al.
Proteome Science|March 19, 2008
Proteomic analysis of the EhV-86 virionMichael J Allen, Julie A Howard, Kathryn S Lilley, et al.
Environmental Microbiology|May 14, 2015
Intragenus competition between coccolithoviruses: an insight on how a select few can come to dominate manyJozef I Nissimov, Johnathan A Napier, Michael J Allen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2010
Giant virus with a remarkable complement of genes infects marine zooplanktonMatthias G Fischer, Michael J Allen, William H Wilson, et al.
British Journal of Clinical Pharmacology|February 19, 2002
Pharmacodynamic effect of continuous vs intermittent dosing of dofetilide on QT intervalMichael J Allen, Stuart D Oliver, Margaret W Newgreen, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Internal Medicine Journal|October 18, 2020
End-of-life intravenous chemotherapy administration patterns in the treatment of Queensland lung and pancreas cancer patients: a 10-year retrospective analysisMichael J Allen, Nathan Dunn, Tracey Guan, et al.
FEBS Open Bio|November 20, 2013
Mutations of an NAD(P)H-dependent flavoprotein monooxygenase that influence cofactor promiscuity and enantioselectivityChantel N Jensen, Sohail T Ali, Michael J Allen, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 12, 2010
Time-dependent measure of a nanoscale force-pulse driven by the axonemal dynein motors in individual live sperm cellsMichael J Allen, Robert E Rudd, Mike W McElfresh, et al.
Journal of Molecular Catalysis. B, Enzymatic|November 11, 2014
Exploring nicotinamide cofactor promiscuity in NAD(P)H-dependent flavin containing monooxygenases (FMOs) using natural variation within the phosphate binding loop. Structure and activity of FMOs from <i>Cellvibrio</i> sp. BR and <i>Pseudomonas stutzeri</i> NF13Chantel N Jensen, Sohail T Ali, Michael J Allen, et al.
British Journal of Clinical Pharmacology|November 18, 2003
Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safetyLynn Purkins, Nolan Wood, Katie Greenhalgh, et al.
Marine Drugs|February 10, 2021
Antiviral Potential of Algal Metabolites-A Comprehensive ReviewAntónio Pagarete, Ana Sofia Ramos, Pål Puntervoll, et al.
Proteome Science|March 19, 2008
Proteomic analysis of the EhV-86 virionMichael J Allen, Julie A Howard, Kathryn S Lilley, et al.
Environmental Microbiology|May 14, 2015
Intragenus competition between coccolithoviruses: an insight on how a select few can come to dominate manyJozef I Nissimov, Johnathan A Napier, Michael J Allen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2010
Giant virus with a remarkable complement of genes infects marine zooplanktonMatthias G Fischer, Michael J Allen, William H Wilson, et al.
British Journal of Clinical Pharmacology|February 19, 2002
Pharmacodynamic effect of continuous vs intermittent dosing of dofetilide on QT intervalMichael J Allen, Stuart D Oliver, Margaret W Newgreen, et al.
Pageof 12